[Isoprostanes: a putative key role in vascular diseases].
Isoprostanes are arachidonic acid metabolites produced by a free-radical-dependent mechanism. The 15-series F2-isoprostanes and some 15-series E2-isoprostanes mediate vasoconstriction in different vascular beds and species. Furthermore, 15-F2t-IsoP induces smooth muscle cells mitogenesis and monocyte adhesion to endothelial cells. In clinical studies, 15-F2t-IsoP levels are increased in vascular disorders involving atherosclerosis, ischemia-reperfusion and inflammation. Whether the effects observed in vitro are observed consistently in vivo at physiological concentrations and whether these effects contribute to pathological states in vivo is still debated.